A wild day with COVID VACCINE STOCKS, after Novavax presents some good news in a Phase I trial. Stat news messed up its news story initially, resulting in a temporary deep dive in after hours. The stock closed at $169.90, up 8.1% after today's trading. Perhaps as a result of Novavax's progress, Moderna dropped 4.2%.
The winning stock today was Vaxart, up 10.4%. Other strong performers were Emergent (which has arrangements with Novavax for production and distribution of the vaccine) was up 8.2%. Inovio was up 7%, for its best day in some time.
Today's loser was GeoVax, down almost 11%. PDS Bio dropped 6.4%.
Overall, it was a relatively flat day with 14 stocks down and 13 up. The average COVID VACCINE STOCK was up 0.7%.
No comments:
Post a Comment